Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease
NCT06664684 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2025-06-26
Summary
Previous studies have investigated the effect of different dietary patterns on metabolic dysfunction-associated fatty liver disease (MAFLD), for which lifestyle modification remains the primary treatment. The present study sought to determine the effect of intermittent fasting on anthropometric measurements, fibroblast growth factor (FGF)-21, and autophagy markers including autophagy-related protein (ATG)-5 and BECLIN-1 levels, as well as on hepatic steatosis and fibrosis levels in overweight or obese patients with MAFLD to elucidate the efficacy of intermittent fasting in the management of MAFLD. The study included 48 patients diagnosed with MAFLD. Patients were randomly assigned into two groups: 22 received a dietary treatment involving 22-25 kcal/kg/day of energy for 8 weeks (energy-restricted diet group), and 26 followed the same dietary intervention and a 16:8 pattern (energy + time-restricted diet group). The patients were assessed for various parameters at baseline (T0) and at the end of the week 8 (T8). The extent of hepatic steatosis and fibrosis was determined using transient elastography on a FibroScan® device. Serum levels of FGF-21, BECLIN-1, and ATG-5 were determined using enzyme-linked immunosorbent assay.
Conditions
- Intermittent Fasting
- Metabolic Dysfunction-Associated Fatty Liver Disease
Interventions
- OTHER
-
Energy-restricted dietary intervention
The diets were planned based on current guidelines, manuals, systematic reviews, and meta-analyses published in recent years on MAFLD \[5-6, 27-28\]. In this diet, carbohydrates constituted 50%-55% of total energy intake, proteins constituted 10%-20%, and fats constituted 25%-35%. The content of the diets was tailored to each patient, considering various factors such as sex, age, and physical activity status.
- OTHER
-
Energy + time-restricted dietary intervention
Patients in the energy + time-restricted diet group followed the same dietary intervention and a 16:8 eating pattern where they were instructed to restrict their energy intake to an 8-h time window and not to consume energy-containing foods or drinks during the remaining 16 h. Participants were allowed to consume energy-free beverages such as water, coffee, and tea during fasting. The timing of the eating window during the day varied according to participants' lifestyles and habits. However, considering the importance of nocturnal fasting, the eating window in all patients started at 10:00-12:00 in the day and ended at 18:00-20:00 in the evening. The energy-restricted diet group did not follow any time restriction in the planning of main meals and snacks.
Sponsors & Collaborators
-
Marmara University
collaborator OTHER -
Istanbul Bilgi University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-23
- Primary Completion
- 2023-01-30
- Completion
- 2023-09-12
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Intermittent Fasting, Mediterranean Diet and NAFLD
NCT06615817 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Time-restricted Feeding in NAFLD
NCT05220956 ·Status: RECRUITING ·Phase: NA
-
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines
NCT06257732 ·Status: RECRUITING ·Phase: NA
-
Alternate Day Fasting, Exercise, and NAFLD
NCT04004403 ·Status: COMPLETED ·Phase: NA
-
Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue Inflammation
NCT02133144 ·Status: UNKNOWN ·Phase: NA
-
Short-term Fat Overfeeding on the Effects of Liver Metabolism
NCT05962190 ·Status: RECRUITING ·Phase: NA
-
Effect of Mediterranean Diet in Obese Adolescents With Nonalcoholic Fatty Liver Disease
NCT04845373 ·Status: COMPLETED ·Phase: NA
-
Aronia and Non-alcoholic Fatty Liver Disease
NCT06450769 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)
NCT01472120 ·Status: UNKNOWN
-
Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study
NCT04440540 ·Status: TERMINATED ·Phase: NA
-
Liver Fat Content and Bariatric Surgery
NCT06064240 ·Status: UNKNOWN
-
Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping
NCT04971434 ·Status: UNKNOWN ·Phase: NA
-
Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver
NCT05623930 ·Status: UNKNOWN ·Phase: NA
-
Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements
NCT05810506 ·Status: COMPLETED
-
Impact of Weight Loss Surgery in Adolescents With NAFLD
NCT02952170 ·Status: COMPLETED ·Phase: NA
-
Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease
NCT00868933 ·Status: COMPLETED ·Phase: NA
-
The Effect of a High-fat vs. High-sugar Diet on Liver Fat Accumulation and Metabolism
NCT03145350 ·Status: COMPLETED ·Phase: NA
-
Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease
NCT06166797 ·Status: NOT_YET_RECRUITING
-
Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD
NCT05866744 ·Status: COMPLETED ·Phase: NA
-
Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease
NCT01894438 ·Status: COMPLETED ·Phase: NA
-
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
NCT04059029 ·Status: UNKNOWN
-
Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients
NCT06627114 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease
NCT06942312 ·Status: ENROLLING_BY_INVITATION
-
A Nutrigenetic Intervention in MASLD
NCT06220695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA